140 related articles for article (PubMed ID: 15097903)
1. Endogenous endophthalmitis caused by Scedosporium apiospermum treated with voriconazole.
Figueroa MS; Fortun J; Clement A; De Arévalo BF
Retina; 2004 Apr; 24(2):319-20. PubMed ID: 15097903
[No Abstract] [Full Text] [Related]
2. Intravitreal voriconazole for the treatment of endogenous endophthalmitis caused by Scedosporium apiospermum.
Chen FK; Chen SD; Tay-Kearney ML
Clin Exp Ophthalmol; 2007; 35(4):382-5. PubMed ID: 17539796
[TBL] [Abstract][Full Text] [Related]
3. Scedosporium apiospermum traumatic endophthalmitis successfully treated with voriconazole.
Zarkovic A; Guest S
Int Ophthalmol; 2007 Dec; 27(6):391-4. PubMed ID: 17901927
[TBL] [Abstract][Full Text] [Related]
4. Endogenous Scedosporium apiospermum endophthalmitis.
Jain A; Egbert P; McCulley TJ; Blumenkranz MS; Moshfeghi DM
Arch Ophthalmol; 2007 Sep; 125(9):1286-9. PubMed ID: 17846376
[No Abstract] [Full Text] [Related]
5. Scedosporium apiospermum eumycetoma successfully treated with oral voriconazole: report of a case and review of the Brazilian reports on scedosporiosis.
Oliveira Fde M; Unis G; Hochhegger B; Severo LC
Rev Inst Med Trop Sao Paulo; 2013; 55(2):121-3. PubMed ID: 23563766
[TBL] [Abstract][Full Text] [Related]
6. Use of voriconazole in Scedosporium apiospermum keratitis.
Lai TF; Malhotra R; Esmail-Zaden R; Galanopoulas A; Chehade M; Selva D
Cornea; 2003 May; 22(4):391; discussion 391-2. PubMed ID: 12792490
[No Abstract] [Full Text] [Related]
7. Successful outcome of Scedosporium apiospermum disseminated infection treated with voriconazole in a patient receiving corticosteroid therapy.
Muñoz P; Marín M; Tornero P; Martín Rabadán P; Rodríguez-Creixéms M; Bouza E
Clin Infect Dis; 2000 Dec; 31(6):1499-501. PubMed ID: 11096022
[TBL] [Abstract][Full Text] [Related]
8. Case of cutaneous Scedosporium apiospermum infection successfully treated with voriconazole.
Matsumoto Y; Oh-I T; Nagai A; Ohyama F; Ooishi T; Tsuboi R
J Dermatol; 2009 Feb; 36(2):98-102. PubMed ID: 19284454
[TBL] [Abstract][Full Text] [Related]
9. Unusual pharmacokinetics of intravitreal and systemic voriconazole in a patient with Scedosporium apiospermum endophthalmitis.
Nochez Y; Arsene S; Le Guellec C; Bastides F; Morange V; Chaumais MC; Pisella PJ
J Ocul Pharmacol Ther; 2008 Feb; 24(1):87-90. PubMed ID: 18370878
[TBL] [Abstract][Full Text] [Related]
10. Scedosporium apiospermum mycetoma with bone involvement successfully treated with voriconazole.
Porte L; Khatibi S; Hajj LE; Cassaing S; Berry A; Massip P; Linas MD; Magnaval JF; Sans N; Marchou B
Trans R Soc Trop Med Hyg; 2006 Sep; 100(9):891-4. PubMed ID: 16714039
[TBL] [Abstract][Full Text] [Related]
11. Activity of voriconazole against corneal isolates of Scedosporium apiospermum.
Shah KB; Wu TG; Wilhelmus KR; Jones DB
Cornea; 2003 Jan; 22(1):33-6. PubMed ID: 12502945
[TBL] [Abstract][Full Text] [Related]
12. Multiple Scedosporium apiospermum brain abscesses after near-drowning successfully treated with surgery and long-term voriconazole: a case report.
Leechawengwongs M; Milindankura S; Liengudom A; Chanakul K; Viranuvatti K; Clongsusuek P
Mycoses; 2007 Nov; 50(6):512-6. PubMed ID: 17944716
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of Scedosporium apiospermum soft tissue abscess with caspofungin and voriconazole in a severely immunocompromised patient with acute myeloid leukemia.
Beier F; Kittan N; Holzmann T; Schardt K; Andreesen R; Holler E; Hildebrandt GC
Transpl Infect Dis; 2010 Dec; 12(6):538-42. PubMed ID: 20604906
[TBL] [Abstract][Full Text] [Related]
14. Correlation between in vitro susceptibility of Scedosporium apiospermum to voriconazole and in vivo outcome of scedosporiosis in guinea pigs.
Capilla J; Guarro J
Antimicrob Agents Chemother; 2004 Oct; 48(10):4009-11. PubMed ID: 15388467
[TBL] [Abstract][Full Text] [Related]
15. Voriconazole in the treatment of fungal osteomyelitis of the orbit in the immunocompromised host.
O'Doherty M; Hannan M; Fulcher T
Orbit; 2005 Dec; 24(4):285-9. PubMed ID: 16354641
[TBL] [Abstract][Full Text] [Related]
16. Multifocal Scedosporium apiospermum spondylitis in a cystic fibrosis patient.
Guignard S; Hubert D; Dupont B; Anract P; Alioua D; Guerini H; Paugam A; Dougados M
J Cyst Fibros; 2008 Jan; 7(1):89-91. PubMed ID: 17567545
[TBL] [Abstract][Full Text] [Related]
17. Disseminated Scedosporium apiospermum infection in renal transplant recipient: long-term successful treatment with voriconazole: a case report.
Rogasi PG; Zanazzi M; Nocentini J; Fantoni E; Trotta M; Faggi E; Fontanelli A; Bertoni E; Salvadori M; Leoncini F
Transplant Proc; 2007; 39(6):2033-5. PubMed ID: 17692684
[TBL] [Abstract][Full Text] [Related]
18. Scedosporium apiospermum soft tissue infection successfully treated with voriconazole: potential pitfalls in the transition from intravenous to oral therapy.
Schaenman JM; DiGiulio DB; Mirels LF; McClenny NM; Berry GJ; Fothergill AW; Rinaldi MG; Montoya JG
J Clin Microbiol; 2005 Feb; 43(2):973-7. PubMed ID: 15695722
[TBL] [Abstract][Full Text] [Related]
19. Anterior chamber exudative mass due to Scedosporium apiospermum in an immunocompetent individual.
Shankar S; Biswas J; Gopal L; Bagyalakshmi R; Therese L; Borse NJ
Indian J Ophthalmol; 2007; 55(3):226-7. PubMed ID: 17456946
[TBL] [Abstract][Full Text] [Related]
20. Cure of orthopaedic infection with Scedosporium prolificans, using voriconazole plus terbinafine, without the need for radical surgery.
Gosbell IB; Toumasatos V; Yong J; Kuo RS; Ellis DH; Perrie RC
Mycoses; 2003 Jun; 46(5-6):233-6. PubMed ID: 12801370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
